Last update 30 Aug 2025

HH-2710

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HH 2710
Target
ERK1 x ERK2
Action
inhibitors
Mechanism
ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic DiseasesRespiratory Diseases+ [2]
Active Indication-
Inactive Indication
Advanced cancerEGFR-mutated non-small Cell Lung CancerErdheim-Chester Disease+ [2]
Originator Organization
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
Active Organization-
Inactive Organization
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
License Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HH-2710
NCT04198818
/ TerminatedPhase 1/2
A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors
100 Clinical Results associated with HH-2710
Login to view more data
100 Translational Medicine associated with HH-2710
Login to view more data
100 Patents (Medical) associated with HH-2710
Login to view more data
100 Deals associated with HH-2710
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
United States
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
23 Jan 2020
Advanced cancerPhase 2
United States
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
23 Jan 2020
Non-Small Cell Lung CancerPhase 2
United States
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
23 Jan 2020
EGFR-mutated non-small Cell Lung CancerPhase 2
United States
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
EGFR-mutated non-small Cell Lung CancerPhase 2
China
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
Erdheim-Chester DiseasePhase 2
United States
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
Erdheim-Chester DiseasePhase 2
China
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
MelanomaPhase 2
United States
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
MelanomaPhase 2
China
Haihe Biopharma Co., Ltd.Haihe Biopharma Co., Ltd.
07 Jan 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free